OKOzan Kandemir

Ozan Kandemir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ozan Kandemir has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Fadime Demir

    Nuclear Medicine Department, Kayseri City Hospital, Şeker Mah. Muhsin Yazicioglu Bulvarı No:77, Kocasinan, 38080 Kayseri, Türkiye

    2 shared publications
  • Ali Muhammedoglu

    Department of Pathology, Istanbul Bagcılar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey

    1 shared publication
  • Atilla Celik

    Department of General Surgery, Istanbul Bagcılar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey

    1 shared publication
  • Aynur Ozen

    Department of Nuclear Medicine, Istanbul Bagcılar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey

    1 shared publication
  • Deniz Söylemez

    Muğla Sıtkı Koçman Üniversitesi Eğitim ve Araştırma Hastanesi

    1 shared publication
  • Emrah Dogan

    Muğla Sıtkı Koçman University

    1 shared publication

Latest Publications

  • Open Access

    Association of Ischemia Localization with Recorded PCI Procedural Category in Patients Undergoing Myocardial Perfusion Imaging

    by Ozan Kandemir, Hakkı Kaya, Emrah Doğan

    Background: Myocardial perfusion imaging (MPI) plays a central role in the noninvasive evaluation of myocardial ischemia and in guiding clinical management in patients with suspected or known coronary artery disease. While ischemic burden is an established component of MPI interpretation, the relationship between ischemia localization and the procedural strategy recorded among patients undergoing percutaneous coronary intervention (PCI) remains less well defined. This study aimed to evaluate whether the anatomical localization of ischemia identified by MPI was associated with the two PCI procedural categories recorded in the study dataset (Stent versus PTCA + stent). Methods: In this retrospective cohort study, 328 patient records were assessed for eligibility and 268 patients with complete MPI localization and treatment data were included. Seven patients received medical therapy alone and 261 underwent percutaneous coronary intervention (PCI); no patient underwent coronary artery bypass grafting (CABG). Within the PCI subgroup, the mutually exclusive patient-level source labels were Stent (including capitalization variants) and PTCA + STENT; no PTCA-only category was present. Because of the small medical-therapy group, inferential analyses were restricted to the 261 PCI patients. The overall association between the 13 ischemia–localization categories and PCI procedural category was assessed using the Fisher–Freeman–Halton exact test with Monte Carlo estimation. Multivariable logistic regression was performed with Stent as the dependent category and age, sex, anterior involvement, and multiregional ischemia as explanatory variables. Results: Among the 261 patients undergoing PCI, 144 were recorded in the Stent category and 117 in the PTCA + stent category. Across all 13 ischemia–localization categories, no statistically significant overall association was observed between ischemia localization and PCI procedural category (Fisher–Freeman–Halton exact test with Monte Carlo estimation, p = 0.7843). In multivariable analysis, anterior involvement (adjusted OR 1.02, 95% CI 0.58–1.82; p = 0.935) and multiregional ischemia (adjusted OR 0.69, 95% CI 0.33–1.41; p = 0.304) were not significantly associated with procedural category. Age was also not significantly associated with procedural category (adjusted OR 1.00, 95% CI 0.97–1.03; p = 0.993). Male sex was associated with lower adjusted odds of being in the Stent category relative to PTCA + stent (adjusted OR 0.40, 95% CI 0.23–0.70; p = 0.0012). Conclusions: In this cohort of patients undergoing PCI, ischemia localization was not significantly associated with the recorded procedural category (Stent versus PTCA + stent). The observed association with sex was secondary and should be interpreted cautiously. Given the very small medical-therapy group, no reliable conclusions can be drawn from this cohort regarding the likelihood of PCI versus medical management or comparative treatment efficacy.

  • Open Access

    Predictive value of 18F-FDG PET/CT tumor SUVmax value in terms of overall survival after neoadjuvant therapy in rectal cancer

    by Fadime Demir, Ozan Kandemir, Gulhan Guler Avcı

    Background: It is known that 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) makes a significant contribution to other diagnostic methods in determining the response to treatment after neoadjuvant chemoradiotherapy (NCRT). The study aimed to determine whether the tumor maximum standardized uptake values (SUVmax) on 18F-FDG PET/CT is predictive of overall survival (OS) in patients with rectal cancer after neoadjuvant treatment and to investigate whether the rate of change in SUVmax has a prognostic value. Materials and methods: This retrospective study included 64 rectal cancer patients who underwent 18F-FDG PET/CT imaging, first for staging and then to assess response to neoadjuvant radiotherapy (NRT). SUVmax1 before and SUVmax2 after treatment were measured from the volume of interest (VOI). To determine the predictive value of 18F-FDG PET/CT SUVmax parameters for death, the area under the curve (AUC) and cut-off values were calculated using Receiver Operator Characteristic (ROC) analysis. Kaplan-Meier analysis was used to evaluate the effect of SUVmax cut of value on OS. Results: Twenty-five (39%) patients were female and 39 (61%) were male. The median follow-up period was 37.5 months. The mean SUVmax1 and SUVmax2 values were 20.1 ± 9.5 and 7.6 ± 4.8, respectively. OS significantly differed when 8.5 was used as a cut-off for SUVmax2 (p = 006). 18F-FDG PET/CT metabolic tumor parameters had no significant predictive value for progression-free survival (PFS). Conclusion: According to the results of our study, SUVmax2 after neoadjuvant treatment had a significant predictive value for OS in patients with recurrent cancer. Keywords: rectal cancer neoadjuvant radiotherapy 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography

  • Open Access

    The Prognostic Significance of Tumor SUVmax Value in Pre- and Post-Chemoradiotherapy 18F-FDG PET/CT Imaging in Patients with Localized and Advanced Head and Neck Squamous Cell Carcinoma

    by O Kandemir, F Demir, GG Avcı

    Background: Some parameters of 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) can predict tumor chemosensitivity and survival in patients with head and neck squamous cell carcinoma (HNSCC). Aim: The aim of the study was to investigate the prognostic value of pre- and post-treatment maximum standardized uptake values (SUVmax) in 18 F-FDG PET/CT imaging for predicting mortality in patients with HNSCC, as well as its prognostic value in terms of disease progression, overall survival (OS), and progression-free survival (PFS). Methods: This retrospective study included 37 patients with a histopathological diagnosis of HNSCCs between 2015 and 2018. In patients with HNSCC, the first 18 F-FDG PET/CT imaging was performed for pre-treatment staging, and the second imaging was performed to evaluate post-treatment response. In these imaging studies, SUVmax values of the primary tumor before and after treatment were determined. After the second imaging, patients were re-evaluated and followed up. ROC analysis was used to determine the predictive value of 18 F-FDG PET/CT SUVmax parameters in terms of death and progression, and Cox regression analysis was used to investigate the prognostic value in terms of OS and PFS. Results: Cut-off value 15 for SUVmax1 (pre-treatment) had a significant predictive value for mortality ( P = 0.02). Cut-off value 3.1 for SUVmax2 (post-treatment) had a significant predictive value for progression ( P = 0.024). In univariate analysis, both SUVmax1 and SUVmax2 values were significant prognostic factors for OS ( P = 0.047, P = 0.004). However, for PFS, only the SUVmax2 value was a significant prognostic factor ( P = 0.001). Conclusion: SUVmax1 value of the primary tumor at diagnosis in HNSCC patients has a predictive value for mortality and a prognostic value for OS. However, the SUVmax2 value in the primary tumor after treatment is a predictive factor for progression and a prognostic factor for both OS and PFS.

  • Open Access

    Comparison between 18F-FDG PET/CT and diffusion-weighted imaging in detection of invasive ductal breast carcinoma.

    by Aynur Ozen, Tarik Sayin, Ozan Kandemir, Ozgul Ekmekcioglu, Serdar Altınay, Eylem Bastug, Ali Muhammedoglu, Atilla Celik, Ramazan Albayrak

    Breast carcinoma is the most common type of cancer in females. This study aims to compare fluorine-18-fluorodeoxyglucose (18F-FDG) uptake pattern and apparent diffusion coefficient (ADC) value for the detection of the primary tumour and axillary metastases of invasive ductal breast carcinoma. This study included 40 breast carcinoma lesions taken from 39 patients. After staging by positron emission tomography-computed tomography (PET/CT) and diffusion-weighted magnetic resonance imaging (MRI), breast surgery with axillary lymph node dissection or sentinel lymph node biopsy was performed. Primary lesion detection rate for PET/CT and diffusion-weighted MRI was high with 39 of 40 lesions (97.5%). The sensitivity and specificity for the detection of metastatic lymph nodes in axilla were 40.9%, 88.9%, with 18F-FDG PET/CT scans and 40.9%, 83.3%, for dw-MRI, respectively. No significant correlation was detected between ADC and SUVmax or SUVmax ratios. Estrogen receptor (p=0.007) and progesterone receptor (p=0.036) positive patients had lower ADC values. Tumour SUVmax was lower in T1 than T2 tumour size (p=0.027) and progesterone receptor-positive patients (p=0.029). Tumour/background SUVmax was lower in progesterone receptor-positive patients (p=0.004). Tumour/liver SUVmax was higher in grade III patients (p=0.035) and progesterone receptor negative status (p=0.043). This study confirmed the high detection rate of breast carcinoma in both modalities. They have same sensitivity for the detection of axillary lymph node metastases, whereas the PET/CT scan had higher specificity. Furthermore, ADC, SUVmax and SUVmax ratios showed some statistical significance among the patient groups according to different pathological parameters.


  • Open Access

    The effect of separate and combined visual evaluation of imaging performed in supine and prone positions in 99m Tc-methoxy-isobutyl-isonitrile (MIBI) myocardial perfusion stress study on the need for rest study in men without a known history of coronary artery disease.

    by Ozan Kandemir

    Introduction:99mTc-methoxy-isobutyl-isonitrile myocardial perfusion imaging (99mTc-MIBI MPI), is the most commonly used noninvasive stress imaging method for the diagnosis of coronary artery disease (CAD) (J1). However, despite its overall effectiveness, the interpretation of MPI is complex due to potential imaging artifacts, including those related to the patient and equipment (J). Soft tissue attenuation, such as that caused by breast position or the diaphragm, is one of the most common factors that can reduce the test accuracy for detecting CAD and affect image quality. (G4). To reduce the factors that decrease quality, methods such as electrocardiography-gated imaging, attenuation correction software, and changing the patient’s position have been proposed (G4, G5). MPI is conventionally performed in the supine position (Y). However, different positions are now being used to achieve better imaging quality (G).One approach that has been reported to improve the diagnostic accuracy of MPI is the use of a supine-prone combination rather than supine MPI alone (C).In recent years, numerous studies have shown significant reductions in both diagnostic performance and patient radiation exposure when using ”stress-first” imaging, such that a normal stress study can eliminate the need for subsequent rest imaging (A31, A32, A33, A34). The normal stress study will eliminate the need for subsequent rest imaging, thereby reducing the examination time, radiation dose, and the doses of radiopharmaceuticals used.In cases of diaphragmatic or breast attenuation, the absence of perfusion defects in stress-prone imaging can help exclude ischemic heart disease, especially when combined with a supine study, thereby reducing the need for rest imaging (O).It has been reported that the addition of prone MPI to supine MPI increases the diagnostic accuracy in populations consisting of both women and men (C6, C7, C8). However, data directly comparing these two imaging strategies, especially in cohorts consisting solely of men, are limited (C).Despite its potential to increase diagnostic accuracy, the combined supine-prone MPI is not widely utilized.In our study, we retrospectively investigated the effect of stress supine-only, stress prone-only, and combined stress supine-prone MPS studies on the need for rest imaging in male patients without known coronary artery disease in whom there is limited data in the literature.

  • An Investigation of the Relationship Between 18F-FDG PET/CT Parameters of Primary Tumors and Lymph Node Metastasis in Resectable Non-small Cell Lung Cancer

    by Ozan Kandemir, Fadime Demir

    Background: Mediastinal lymph node metastasis is an important prognostic factor in non-small cell lung cancer (NSCLC) patients without distant metastases. 18F-2-fluoro-2-deoxy-Dglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) is recommended for detecting and staging lymph nodes and distant metastases in NSCLC patients. Objective: This study aims to investigate whether maximum standardized uptake (SUVmax), mean standardized uptake (SUVmean), metabolic tumor volume (MTV), and tumor lesion glycolysis (TLG) values of the primary tumor measured by 18F-FDG PET/CT in resectable NSCLC can predict preoperative lymph node metastasis. Methods: This retrospective study included eighty NSCLC patients who underwent preoperative Positron Emission Tomography/Computed Tomography (PET/CT) for diagnosis and staging. The patients were stage I–III and had no distant metastases. Tumor metabolic parameters such as SUVmax, SUVmean, MTV, and TLG at PET/CT imaging were measured for preoperative diagnosis and staging, and the postoperative pathology results of the patients were examined. The pathology results divided patients into two groups; with and without lymph node metastasis. The groups were compared with student's t-test and chi-square test with regard to 18F-FDG PET/CT tumor metabolic parameters and other parameters. Results: Fifteen (18.8%) patients were female, and 65 (81.3%) were male. According to the postoperative pathology results, while 30 (37.5%) patients had lymph node metastasis, 50 (62.5%) did not. There was a significant difference between the groups regarding tumor SUVmax and SUVmean values (p = 0.036, p = 0.045). Overall survival in the N0 group was significantly higher than in the N1 + N2 group (p = 0.034); median survival was 30.2 months in N0 group and 27.3 months in N1 and N2 groups. Conclusion: SUVmax and SUVmean values are significantly higher in patients with lymph node metastases than in patients without lymph node metastases, and this finding may provide useful information for predicting lymph node metastasis in patients with resectable NSCLC.


  • Open Access

    FIRST CASE REPORT OF ANCA-ASSOCIATED VASCULITIS AND ANTHRACOSIS COEXISTENCE

    by Emrah Dogan, Ozan Kandemir, Özge Oral Tapan, Utku Tapan, Sabri Serhan Olcay, Özgür İlhan Çelik, Marwa Mouline Doğan

    Anthracosis is a type of mild pneumoconiosis secondary to harmless carbon dust deposits. Although anthracosis was previously associated with inhaled coal particles, such as coal workers' pneumoconiosis, this hypothesis was later abandoned; pathology has been associated with inhaled dust particles. Our paper is the first case report of ANCA-associated vasculitis and anthracosis coexistence. In addition, it aims to highlight that histopathologically proven anthracotic granulomatous nodules can show high FDG uptake in PET/CT contrary to expectation. We present a case of a 73-year-old male with p-ANCA-associated vasculitis and anthracotic lung nodules accompanied by radiological and clinical findings. The patient got diagnosis with p-ANCA-associated vasculitis with serological and rheumatological tests. Atypically, the clinical findings of the patient were weak (No dyspnoea, cough or additional pulmonary complaints). Nodules were present on X-ray graphics and nodules’ contours were irregular on CT. On PET/CT, SUV values of the nodules were high [12 kBq/mL]. Histopathological specimens showed multiple lung granulomas including anthracosis particles. Until performing the biopsy, we could not exclude the possibility of malignancy. Conclusion: When lung involvement of vasculitis is superimposed by anthracosis, it can create granulomas with high SUV values. The relationship between anthracosis and parenchymal lung diseases is a current topic and many recently published papers are present on this subject. To the best of our knowledge, our paper is the first paper showing the relationship between parenchymal involvement of vasculitis and anthracosis in the literature. Environmental pollution and dust particles are the known reasons for anthracosis particles in the nodules. It is open to future research on whether air pollution triggers new atypical cases or not.

  • THE ROLE OF PET CT IN CANCER OF UNKNOWN PRIMARY

    by Ozan Kandemi̇r, Fadime Demi̇r

    Objective: This study aimed to investigate the diagnostic value of positron emission tomography/computed tomography (PET/CT) in detecting the primary focus and in suspicious foci in patients who underwent PET/CT with a pre-diagnosis of carcinoma of unknown primary. Material and Methods: In this retrospective study, a total of 49 patients who underwent PET/CT scan with a prediagnosis of carcinoma of the unknown primary between 2015 and 2019, and whose clinical follow-up and histopathological data were available, were included.PET/CT study was performed in 20 (40%) patients after the metastatic lesion was detected as a result of pathology, and in 29 (60%) patients due to clinical findings and imaging methods and suspicion of malignancy. The histopathological and clinical evaluation of the patients before PET/CT and the primary surgery, histopathological examinations and clinical follow-ups after PET/CT were examined. The success of PET/CT in detecting primary lesions and evaluating suspicious lesions in metastatic cases was analyzed. Results: Seventeen (34.7%) of the patients were female and 32 (65.3%) were male. A primary malignant tumor was detected in 34 (85%) of 40 patients with PET/CT. Regional distribution in patients with primary cancer focus; 9 pancreases, 9 lungs, 4 livers, 3 urothelial, 2 thyroids, 1 vertebra, 1 breast, 1 ovary, 1 esophagus, 1 prostate, 1 iliac bone, 1 skin, 1 stomach and 1 colon. In the follow-up of 6 cases whose primary could not be determined; Cervical cancer was detected in 1, ovarian cancer in 1, and the primary focus could not be detected in the clinical follow-up of 4 metastatic patients. Conclusion: PET/CT is highly successful in detecting cancers whose primary is unknown. Therefore, PET/CT is a diagnostic imaging method for the detection of the primary in cancer patients whose primary is unknown. Keywords: Cancer of unknown primary; Positron emission tomography; Malignant lesion

  • Open Access

    The Effect of Empirical Fixed-Dose Radioactive Iodine Administration on Treatment Success in Patients with Hyperthyroidism and its Comparison with Sensitive Dosimetric Methods in the Literature

    by Ozan Kandemi̇r, Osman Kupik

    Çalışmamızda kliniğimizde hipertiroidi nedeniyle ampirik sabit doz ile uyguladığımız radyoaktif iyot tedavisinin (RIT) başarısının, diğer bir yöntem olan hassas dozimetrik doz hesaplama ile uygulanan RIT’ın literatürdeki başarısı ile karşılaştırmayı amaçladık. Hipertiroidi nedeniyle kliniğimizde RIT uygulanan 206 hastanın dosyasını incelendik. Cinsiyet, yaş gibi demografik özellikler ile tiroid sintigrafisi, tiroid fonksiyon testlerini (TSH ve sT4) değerlendirdik. RIT sonrası en az altı aylık takipleri yapıldı. RIT sonrası 177 hastada (%85.9) ilk altı ayda ötiroidi veya hipotiroidi izlendi ve tedavi başarılı kabul edildi. Otuz sekiz hastada ise (%14.1) ilk altı ayda ötiroidi veya hipotiroidi izlenmedi ve bu hastalarda RIT başarısız kabul edildi. Cinsiyet ve yaş ile tedavi başarısı arasında istatistiksel anlamlı ilişki bulunmadı. Toksik multinoduler guatr izlenen gruptaki başarı oranı diffüz hiperaktif tiroid bezi ve toksik adenomlu diğer iki gruptan daha düşüktü. Tedavi öncesindeki TSH değeri yüksek olanlarda tedavi başarısı daha yüksek idi. Hipertiroidili hastalarda ampirik sabit dozda uygulanan RIT başarılı bir yöntem olduğu ve literatürdeki hassas dozimetrik yöntemle hesaplanan doz ile uygulanan RIT ile benzer başarı oranına sahip olduğu sonucuna vardık. Bu nedenle sabit doz uygulaması daha fazla hasta rahatlığı, zaman tasarrufu sağlamak, aynı zamanda tıbbi maliyetleri düşürmek için uygun ve başarılı bir yöntem olarak kullanılabilir.


  • TOKSİK NODÜLER GUATR HASTALARINDA TİROİD NODÜLÜNÜN MORFOLOJİK ÖZELLİKLERİNİN RADYOAKTİF İYOT TEDAVİSİ SONUÇLARINA ETKİSİ

    by Deniz Söylemez, Ozan Kandemi̇r, Levent Akca, Taner Erselcan

    ÖZET: Amaç: Radyoaktif iyot tedavisi (RAIT) alan toksik nodüler guatr (TNG) tanısı ile takipli hastalarda cinsiyet, yaş, nodülün çapı, nodülün kistik ve solid morfolojik özellikleri, RAIT öncesinde antitiroid tedavi (ATT) kullanımı ve uygulanan RAI dozunun, tedavi sonuçları üzerine etkilerini değerlendirmektir. Gereç ve Yöntemler: 2015-2016 yılları arasında TNG tanısı ile RAIT uygulanan 50 hasta (yaş ort:65±11.7) çalışmaya alındı. Hastaların cinsiyet, yaş gibi dermografik özellikleri ile tedavi öncesi tiroid sintigrafisi, tiroid ultrasonografi sonuçları ve ATT durumları; tedavi sonrası tiroid fonksiyon testleri değerlendirildi. Nodüllerin kistik yada solid komponent içerikleri ultrasonografik ve sintigrafik olarak belirlendi. Nodül çapı olan hastalara 740MBqI-131 olacak şekilde sabit doz RAIT uygulandı. 1., 3. ve 6. ay tiroid foksiyon testleri sonuçları ile takibe alındı. 6. ayda ötiroidi ve hipotiroidi gelişen hastalar tam kür olarak kabul edildi. Bulgular: RAIT sonrasındaki takiplerde 50 hastanın 6. aydaki kür oranı % 86 idi. Hastaların %72’sinde (n:36) ötiroidi, %14’ünde (n:7) hipotiroidi görülürken; %14’ünde (n:7) hipertiroidi mevcuttu. Kadın hastalarda tam kür oranı %94 iken, erkeklerde %71 idi. Yaş ve antitiroid tedavi ile tedavi etkinliği arasında anlamlı ilişki bulunamadı. Ancak nodül çapı 2 cm’in üstünde olan solid komponent içeren TNG’lı hastalarda RAIT’inin kistik komponent içeren TNG hastalarından daha başarılı olduğu bulundu (Tam kür oranları 2cm üstünde solid nodül %90.91, 2cm üstünde kistik nodül:%75). Sonuç: TNG tanısı ile takipli hastalarda RAIT oldukça başarılı bir yöntemdir. Nodül çapı, nodülün kistik ve soild komponent içeriği ve RAI dozu tedavi etkinliği açısından önemli faktörlerdendir. Ancak yaş ve antitiroid ilaç kullanımı RAIT sonuçlarını etkilememektedir. Anahtar Sözcükler: Radyoaktif iyot tedavisi; Hipertiroidizm; Toksik nodüler guatr ABSTRACT Objective: We aimed to evaluate the effects of the gender, age, diameter and cystic or solid morphological characteristics of the nodule, use of antithyroid therapy (ATT) and radioactive iodine (RAI) dose on treatment results of toxic nodular goiter patients who received radioactive iodine therapy (RAIT). Method: Fifty patients (mean age: 65 ± 11.7 years) who underwent RAIT with a diagnosis of TNG between 2015 and 2016 were included in the study. Demographic characteristics of the patients such as gender, age, pre-treatment thyroid scintigraphy, thyroid ultrasonography results and ATT status; post-treatment thyroid function tests were evaluated. Cystic or solid component contents of the nodules were determined ultrasonographically and scintigraphically. Fixed dose of RAI was applied to patients with nodule diameter 2cm, 740MBq I-131. They were followed up with the results of thyroid function tests at 1st, 3rd and 6th months. Patients who developed euthyroidism and hypothyroidism at 6th month were accepted as complete cure. Findings: The cure rate of 50 patients at 6 months after RAIT was 86%. Euthyroidism was observed in 72% (n: 36) of the patients and hypothyroidism in 14% (n: 7); 14% (n: 7) had hyperthyroidism. While the complete cure rate was 94% in female patients, it was 71% in men. RAIT was found to be more successful in patients with TNG containing a solid component with a nodule diameter greater than 2 cm than TNG patients containing cystic components (full cure rates 90.9% in solid nodules > 2 cm, 75% in cystic nodules > 2 cm). There was no significant relationship between age, ATT and treatment efficacy. Conclusion: RAIT is a very successful method in patients with TNG. We found that nodule diameter, cystic and solid component content of the nodule and RAI dose are important factors in terms of treatment efficiency. However, age and use of antithyroid drugs did not have efficacy on RAIT results. Keywords: Radioactive iodine therapy; Hyperthyroidism; Toxic nodular goiter